The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer.
NCT ID: NCT04252560
Last Updated: 2024-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
45 participants
OBSERVATIONAL
2020-01-31
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Patients With High C-reactive Protein After Scheduled Resection of Colorectal Cancer
NCT03097276
A Multicenter Study on the Safety and Functionality Evaluation of Anastomotic Redo Surgery
NCT07279961
Intestinal Microecological Dysregulation Caused by Appendectomy Increases the Risk of Colorectal Cancer
NCT05066048
Safety and Feasibility of Laparoscopic Intracorporeal Anastomosis for Colorectal Surgery- A Multiple Center Real World Study
NCT05911152
Effectiveness and Safety Study on Different Timing of Preventive Ileostomy Closure After Surgery for Rectal Cancer
NCT02665026
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Colorectal
30 patients operated for colorectal cancer
Colectomy, CRS+HIPEC
No special interventions are going to be performed. Fecal samples are going to be taken and analysed
HIPEC
15 patients operated with CRS+HIPEC for peritoneal carcinomatosis
Colectomy, CRS+HIPEC
No special interventions are going to be performed. Fecal samples are going to be taken and analysed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colectomy, CRS+HIPEC
No special interventions are going to be performed. Fecal samples are going to be taken and analysed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* curative operation planed
* direct anastomose plan
* elective surgery
* All patients with appendix, colon or rectal cancer accepted for CRS+HIPEC
Exclusion Criteria
* antibiotics treatment in the last 6 months
* acute surgery
* palliative surgery
* Ulcerös colitis or Crohns disease
* Prior colectomy
* Small intestine stoma before the operation
* neoadjuvant treatment
* Colon preparation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Konstantinos Tsimogiannis
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uppsala University Hospital
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-04562
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.